Yüklüyor......
Can pimavanserin help patients with Parkinson disease psychosis?
Pimavanserin is a first-in-class selective serotonin 5-HT(2A) receptor inverse agonist approved for the treatment of Parkinson disease psychosis. This article discusses pimavanserin’s mechanism of action, which patients are appropriate candidates for therapy, adverse reactions, and appropriate dosin...
Kaydedildi:
| Yayımlandı: | JAAPA |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6764088/ https://ncbi.nlm.nih.gov/pubmed/30589736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.JAA.0000547757.46299.3d |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|